LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 90

Search options

  1. Book ; Online ; E-Book: Cassidy and Allanson's management of genetic syndromes

    Allanson, Judith E. / Carey, John C. / Battaglia, Agatino / Viskochil, David H. / Cassidy, Suzanne B.

    2021  

    Title variant Management of genetic syndromes
    Author's details edited by John C. Carey, Agatino Battaglia, David Viskochil, Suzanne B. Cassidy
    Keywords Electronic books ; Hereditary Diseases / diagnosis ; Hereditary Diseases / therapy ; Abnormalities, Multiple / diagnosis ; Abnormalities, Multiple / therapy
    Language English
    Size 1 Online-Ressource (xxxv, 1068 Seiten), Illustrationen
    Edition Fourth edition
    Publisher Wiley Blackwell
    Publishing place Hoboken, NJ
    Publishing country United States
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    HBZ-ID HT020617102
    ISBN 978-1-119-43264-7 ; 9781119432678 ; 1-119-43264-2 ; 1119432677
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  2. Article ; Online: Disorders of the ras pathway: an introduction.

    Viskochil, David H

    American journal of medical genetics. Part C, Seminars in medical genetics

    2011  Volume 157C, Issue 2, Page(s) 79–82

    MeSH term(s) Abnormalities, Multiple/genetics ; Abnormalities, Multiple/metabolism ; Animals ; Genetic Diseases, Inborn/genetics ; Genetic Diseases, Inborn/metabolism ; Humans ; Phosphorylation ; Proto-Oncogene Proteins p21(ras)/genetics ; Proto-Oncogene Proteins p21(ras)/metabolism ; Signal Transduction/physiology
    Chemical Substances Proto-Oncogene Proteins p21(ras) (EC 3.6.5.2)
    Language English
    Publishing date 2011-05-15
    Publishing country United States
    Document type Introductory Journal Article
    ZDB-ID 2108622-9
    ISSN 1552-4876 ; 0148-7299 ; 1552-4868
    ISSN (online) 1552-4876
    ISSN 0148-7299 ; 1552-4868
    DOI 10.1002/ajmg.c.30301
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Personal journeys to and in human genetics and dysmorphology.

    Schwartz, Charles E / Aylsworth, Arthur S / Allanson, Judith / Battaglia, Agatino / Carey, John C / Curry, Cynthia J / Davies, Kay E / Eichler, Evan E / Graham, John M / Hall, Bryan / Hall, Judith G / Holmes, Lewis B / Hoyme, H Eugene / Hunter, Alasdair / Innis, Jeffrey / Johnson, John / Keppler-Noreuil, Kim M / Leroy, Jules G / Moore, Cynthia /
    Nelson, David L / Neri, Giovanni / Opitz, John M / Picketts, David / Raymond, F Lucy / Shalev, Stavit Allon / Stevenson, Roger E / Stumpel, Connie T R M / Sutherland, Grant / Viskochil, David H / Weaver, David D / Zackai, Elaine H

    American journal of medical genetics. Part A

    2024  Volume 194, Issue 6, Page(s) e63514

    Abstract: Genetics has become a critical component of medicine over the past five to six decades. Alongside genetics, a relatively new discipline, dysmorphology, has also begun to play an important role in providing critically important diagnoses to individuals ... ...

    Abstract Genetics has become a critical component of medicine over the past five to six decades. Alongside genetics, a relatively new discipline, dysmorphology, has also begun to play an important role in providing critically important diagnoses to individuals and families. Both have become indispensable to unraveling rare diseases. Almost every medical specialty relies on individuals experienced in these specialties to provide diagnoses for patients who present themselves to other doctors. Additionally, both specialties have become reliant on molecular geneticists to identify genes associated with human disorders. Many of the medical geneticists, dysmorphologists, and molecular geneticists traveled a circuitous route before arriving at the position they occupied. The purpose of collecting the memoirs contained in this article was to convey to the reader that many of the individuals who contributed to the advancement of genetics and dysmorphology since the late 1960s/early 1970s traveled along a journey based on many chances taken, replying to the necessities they faced along the way before finding full enjoyment in the practice of medical and human genetics or dysmorphology. Additionally, and of equal importance, all exhibited an ability to evolve with their field of expertise as human genetics became human genomics with the development of novel technologies.
    MeSH term(s) Humans ; Genetics, Medical ; History, 20th Century ; History, 21st Century ; Human Genetics
    Language English
    Publishing date 2024-02-08
    Publishing country United States
    Document type Journal Article ; Historical Article
    ZDB-ID 2108614-X
    ISSN 1552-4833 ; 0148-7299 ; 1552-4825
    ISSN (online) 1552-4833
    ISSN 0148-7299 ; 1552-4825
    DOI 10.1002/ajmg.a.63514
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A likely HOXC4 predisposition variant for Chiari malformations.

    Brockmeyer, Douglas L / Cheshier, Samuel H / Stevens, Jeff / Facelli, Julio C / Rowe, Kerry / Heiss, John D / Musolf, Anthony / Viskochil, David H / Allen-Brady, Kristina L / Cannon-Albright, Lisa A

    Journal of neurosurgery

    2022  Volume 139, Issue 1, Page(s) 266–274

    Abstract: Objective: Inherited variants predisposing patients to type 1 or 1.5 Chiari malformation (CM) have been hypothesized but have proven difficult to confirm. The authors used a unique high-risk pedigree population resource and approach to identify rare ... ...

    Abstract Objective: Inherited variants predisposing patients to type 1 or 1.5 Chiari malformation (CM) have been hypothesized but have proven difficult to confirm. The authors used a unique high-risk pedigree population resource and approach to identify rare candidate variants that likely predispose individuals to CM and protein structure prediction tools to identify pathogenicity mechanisms.
    Methods: By using the Utah Population Database, the authors identified pedigrees with significantly increased numbers of members with CM diagnosis. From a separate DNA biorepository of 451 samples from CM patients and families, 32 CM patients belonging to 1 or more of 24 high-risk Chiari pedigrees were identified. Two high-risk pedigrees had 3 CM-affected relatives, and 22 pedigrees had 2 CM-affected relatives. To identify rare candidate predisposition gene variants, whole-exome sequence data from these 32 CM patients belonging to 24 CM-affected related pairs from high-risk pedigrees were analyzed. The I-TASSER package for protein structure prediction was used to predict the structures of both the wild-type and mutant proteins found here.
    Results: Sequence analysis of the 24 affected relative pairs identified 38 rare candidate Chiari predisposition gene variants that were shared by at least 1 CM-affected pair from a high-risk pedigree. The authors found a candidate variant in HOXC4 that was shared by 2 CM-affected patients in 2 independent pedigrees. All 4 of these CM cases, 2 in each pedigree, exhibited a specific craniocervical bony phenotype defined by a clivoaxial angle less than 125°. The protein structure prediction results suggested that the mutation considered here may reduce the binding affinity of HOXC4 to DNA.
    Conclusions: Analysis of unique and powerful Utah genetic resources allowed identification of 38 strong candidate CM predisposition gene variants. These variants should be pursued in independent populations. One of the candidates, a rare HOXC4 variant, was identified in 2 high-risk CM pedigrees, with this variant possibly predisposing patients to a Chiari phenotype with craniocervical kyphosis.
    MeSH term(s) Humans ; Genetic Predisposition to Disease/genetics ; Genotype ; Homeodomain Proteins/genetics ; Mutation ; Pedigree ; Phenotype ; Risk Factors ; Brain/abnormalities
    Chemical Substances Homeodomain Proteins ; HOXC4 protein, human
    Language English
    Publishing date 2022-11-25
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3089-2
    ISSN 1933-0693 ; 0022-3085
    ISSN (online) 1933-0693
    ISSN 0022-3085
    DOI 10.3171/2022.10.JNS22956
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: It takes two to tango: mast cell and Schwann cell interactions in neurofibromas.

    Viskochil, David H

    The Journal of clinical investigation

    2003  Volume 112, Issue 12, Page(s) 1791–1793

    Abstract: Neurofibromas are benign tumors comprised primarily of Schwann cells and fibroblasts. Mast cell infiltration is a well-known phenomenon; however, their role in tumor pathogenesis has been enigmatic. In an elegant set of experiments using cells derived ... ...

    Abstract Neurofibromas are benign tumors comprised primarily of Schwann cells and fibroblasts. Mast cell infiltration is a well-known phenomenon; however, their role in tumor pathogenesis has been enigmatic. In an elegant set of experiments using cells derived from a murine model of neurofibromatosis 1 (NF1), Yang et al. dissect the molecular pathways involved in mast cell migration to neurofibromin-deficient Schwann cells. These results set the stage for rational development of therapeutics that could influence the multicellular microenvironment of neurofibromas to inhibit the development and/or progression of these tumors in human NF1.
    MeSH term(s) Alleles ; Animals ; Disease Progression ; Fibroblasts/metabolism ; Humans ; Mast Cells/metabolism ; Mice ; Mice, Transgenic ; Models, Biological ; Mutation ; Neoplasms/metabolism ; Neurofibroma/metabolism ; Neurofibromin 1/metabolism ; Schwann Cells/metabolism ; Signal Transduction ; Stem Cell Factor/metabolism
    Chemical Substances Neurofibromin 1 ; Stem Cell Factor
    Language English
    Publishing date 2003-12
    Publishing country United States
    Document type Comment ; Journal Article ; Review
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI20503
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Growth patterns for untreated individuals with MPS I: Report from the international MPS I registry.

    Viskochil, David / Clarke, Lorne A / Bay, Luisa / Keenan, Hillary / Muenzer, Joseph / Guffon, Nathalie

    American journal of medical genetics. Part A

    2019  Volume 179, Issue 12, Page(s) 2425–2432

    Abstract: Mucopolysaccharidosis Type I (MPS I), caused by deficiency of α-L-iduronidase results in progressive, multisystemic disease with a broad phenotypic spectrum including patients with severe (Hurler syndrome) to attenuated (Hurler-Scheie and Scheie ... ...

    Abstract Mucopolysaccharidosis Type I (MPS I), caused by deficiency of α-L-iduronidase results in progressive, multisystemic disease with a broad phenotypic spectrum including patients with severe (Hurler syndrome) to attenuated (Hurler-Scheie and Scheie syndromes) disease. Disordered growth is common with either phenotype. The study objectives were to construct sex- and age-specific estimated length/height and head circumference growth curves for untreated individuals with severe and attenuated disease and compare them with clinical reference standards. Untreated individuals in the MPS I Registry with at least one observation for length/height and/or head circumference and assigned phenotype as of May 2017 were included. Median growth for 463 untreated individuals with severe disease deviated from reference growth curves by ~6 months of age and fell below the third percentile by 4 years of age. Median head circumference was above reference curves from 3 to 4 months through 3 years of age. Among 207 individuals with untreated attenuated disease, median height fell below the third percentile by 9 years of age with divergence from reference curves by 2 years of age. MPS I-specific growth curves will be useful in evaluation of long-term outcomes of therapeutics interventions and will provide a foundation for understanding the pathogenesis of skeletal disease in MPS I.
    MeSH term(s) Child, Preschool ; Female ; Growth Charts ; Humans ; Infant ; Infant, Newborn ; Male ; Mucopolysaccharidosis I/diagnosis ; Mucopolysaccharidosis I/epidemiology ; Mucopolysaccharidosis I/genetics ; Mucopolysaccharidosis I/therapy ; Phenotype ; Population Surveillance ; Registries
    Language English
    Publishing date 2019-10-22
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2108614-X
    ISSN 1552-4833 ; 0148-7299 ; 1552-4825
    ISSN (online) 1552-4833
    ISSN 0148-7299 ; 1552-4825
    DOI 10.1002/ajmg.a.61378
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.

    Ullrich, Nicole J / Prabhu, Sanjay P / Packer, Roger J / Goldman, Stewart / Robison, Nathan J / Allen, Jeffrey C / Viskochil, David H / Gutmann, David H / Perentesis, John P / Korf, Bruce R / Fisher, Michael J / Kieran, Mark W

    Pediatric blood & cancer

    2020  Volume 68, Issue 4, Page(s) e28833

    Abstract: Data for visual acuity (VA) after treatment of neurofibromatosis type 1-associated optic pathway gliomas (NF1-OPGs) are limited. We retrospectively collected VA, converted to logMAR, before and after targeted therapy with everolimus for NF1-OPG, and ... ...

    Abstract Data for visual acuity (VA) after treatment of neurofibromatosis type 1-associated optic pathway gliomas (NF1-OPGs) are limited. We retrospectively collected VA, converted to logMAR, before and after targeted therapy with everolimus for NF1-OPG, and compared to radiologic outcomes (14/18 with NF1-OPG, 25 eyes [three without quantifiable vision]). Upon completion of treatment, VA was stable in 19 eyes, improved in four eyes, and worsened in two eyes; visual and radiologic outcomes were discordant. In summary, the majority of children with NF1-OPG exhibited stabilization of their VA after everolimus treatment. A larger, prospective study will help delineate visual outcomes after targeted therapy.
    MeSH term(s) Adolescent ; Adult ; Antineoplastic Agents/therapeutic use ; Child ; Child, Preschool ; Everolimus/therapeutic use ; Female ; Humans ; Infant ; Male ; Neurofibromatosis 1/drug therapy ; Neurofibromatosis 1/physiopathology ; Optic Nerve Glioma/drug therapy ; Optic Nerve Glioma/physiopathology ; Retrospective Studies ; Treatment Outcome ; Visual Acuity/drug effects ; Young Adult
    Chemical Substances Antineoplastic Agents ; Everolimus (9HW64Q8G6G)
    Language English
    Publishing date 2020-12-18
    Publishing country United States
    Document type Clinical Trial, Phase II ; Journal Article ; Multicenter Study ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2131448-2
    ISSN 1545-5017 ; 1545-5009
    ISSN (online) 1545-5017
    ISSN 1545-5009
    DOI 10.1002/pbc.28833
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Racial/ethnic disparities and incidence of malignant peripheral nerve sheath tumors: results from the Surveillance, Epidemiology, and End Results Program, 2000-2014.

    Peckham-Gregory, Erin C / Montenegro, Roberto E / Stevenson, David A / Viskochil, David H / Scheurer, Michael E / Lupo, Philip J / Schiffman, Joshua D

    Journal of neuro-oncology

    2018  Volume 139, Issue 1, Page(s) 69–75

    Abstract: Background: Malignant peripheral nerve sheath tumors (MPNSTs) are rare tumors, generally high-grade, and comprise ~ 5-10% of soft tissue sarcomas. Over two-thirds of MPNSTs metastasize, and upwards of 40% clinically recur. Etiologic risk factors for ... ...

    Abstract Background: Malignant peripheral nerve sheath tumors (MPNSTs) are rare tumors, generally high-grade, and comprise ~ 5-10% of soft tissue sarcomas. Over two-thirds of MPNSTs metastasize, and upwards of 40% clinically recur. Etiologic risk factors for MPNSTs are historically understudied. There is evidence to suggest MPNST incidence differs across racial/ethnic groups in pediatric populations. Therefore, we sought to estimate differences in MPNST incidence by race/ethnicity among all ages in the United States.
    Methods: Incidence data were obtained from the Surveillance, Epidemiology, and End Results (SEER-18) Program, 2000-2014. Race/ethnicity was categorized as: White; Black; Asian; Other; and Latino/a ("Spanish-Hispanic-Latino"). Latino/a included all races, while all other categories excluded those identified as Latino/a. Age-adjusted incidence rate ratios (IRR) and 95% confidence intervals (CIs) were generated in SEER-STAT (v8.3.4). We estimated incidence rates among all ages, and among those diagnosed < 25 and ≥ 25 years.
    Results: MPNST cases were abstracted from SEER-18 (n = 1047). Among all age groups, Blacks experienced an elevated incidence of MPNSTs compared to Whites (IRR
    Conclusions: Incidence rates of MPNSTs were highest in Blacks compared to Whites and other minority groups. This study suggests specific patterns exist in terms of race/ethnicity and age at diagnosis of MPNSTs.
    MeSH term(s) Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Continental Population Groups ; Ethnic Groups ; Female ; Humans ; Incidence ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Nerve Sheath Neoplasms/ethnology ; SEER Program ; United States/epidemiology ; Young Adult
    Language English
    Publishing date 2018-04-16
    Publishing country United States
    Document type Journal Article
    ZDB-ID 604875-4
    ISSN 1573-7373 ; 0167-594X
    ISSN (online) 1573-7373
    ISSN 0167-594X
    DOI 10.1007/s11060-018-2842-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Evaluation of racial disparities in pediatric optic pathway glioma incidence: Results from the Surveillance, Epidemiology, and End Results Program, 2000-2014.

    Peckham-Gregory, Erin C / Montenegro, Roberto E / Stevenson, David A / Viskochil, David H / Scheurer, Michael E / Lupo, Philip J / Schiffman, Joshua D

    Cancer epidemiology

    2018  Volume 54, Page(s) 90–94

    Abstract: Background: Racial predilection to pediatric cancer exists; however optic pathway glioma (OPG) risk differences by race/ethnicity are undefined. We estimated differences in OPG incidence across racial/ethnic groups in a multi-state cancer surveillance ... ...

    Abstract Background: Racial predilection to pediatric cancer exists; however optic pathway glioma (OPG) risk differences by race/ethnicity are undefined. We estimated differences in OPG incidence across racial/ethnic groups in a multi-state cancer surveillance registry in the United States.
    Methods: OPG data were obtained from the Surveillance, Epidemiology, and End Results (SEER-18) Program, 2000-2014. Race/ethnicity was categorized as: White; Black; Asian; Other; and Latino/a ("Spanish-Hispanic-Latino"). Latino/a included all races, while all other categories excluded those identified as Latino/a. Age-adjusted incidence rates and rate ratios (IRR) with 95% confidence intervals (CIs) were generated in SEER-STAT (v8.3.4).
    Results: Data on 709 OPG cases ages 0-19 were abstracted from SEER-18. Minority children experienced lower age-adjusted OPG incidence rates compared to White children (IRR
    Conclusions: Incidence of OPGs was highest among White children. This study represents one of the largest to assess differences in OPG susceptibility by race/ethnicity. These findings may inform future studies that seek to evaluate modifying factors for this pediatric tumor including tumorigenesis, treatment, outcome, and long-term late effects.
    MeSH term(s) Adolescent ; Adult ; Child ; Child, Preschool ; Continental Population Groups/statistics & numerical data ; Ethnic Groups/statistics & numerical data ; Female ; Humans ; Incidence ; Infant ; Infant, Newborn ; Male ; Minority Groups/statistics & numerical data ; Optic Nerve Glioma/epidemiology ; Optic Nerve Glioma/ethnology ; Registries ; SEER Program ; United States/epidemiology ; Young Adult
    Language English
    Publishing date 2018-04-21
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2508729-0
    ISSN 1877-783X ; 1877-7821
    ISSN (online) 1877-783X
    ISSN 1877-7821
    DOI 10.1016/j.canep.2018.04.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.

    Cortes-Ciriano, Isidro / Steele, Christopher D / Piculell, Katherine / Al-Ibraheemi, Alyaa / Eulo, Vanessa / Bui, Marilyn M / Chatzipli, Aikaterini / Dickson, Brendan C / Borcherding, Dana C / Feber, Andrew / Galor, Alon / Hart, Jesse / Jones, Kevin B / Jordan, Justin T / Kim, Raymond H / Lindsay, Daniel / Miller, Colin / Nishida, Yoshihiro / Proszek, Paula Z /
    Serrano, Jonathan / Sundby, R Taylor / Szymanski, Jeffrey J / Ullrich, Nicole J / Viskochil, David / Wang, Xia / Snuderl, Matija / Park, Peter J / Flanagan, Adrienne M / Hirbe, Angela C / Pillay, Nischalan / Miller, David T

    Cancer discovery

    2023  Volume 13, Issue 3, Page(s) 654–671

    Abstract: Malignant peripheral nerve sheath tumor (MPNST), an aggressive soft-tissue sarcoma, occurs in people with neurofibromatosis type 1 (NF1) and sporadically. Whole-genome and multiregional exome sequencing, transcriptomic, and methylation profiling of 95 ... ...

    Abstract Malignant peripheral nerve sheath tumor (MPNST), an aggressive soft-tissue sarcoma, occurs in people with neurofibromatosis type 1 (NF1) and sporadically. Whole-genome and multiregional exome sequencing, transcriptomic, and methylation profiling of 95 tumor samples revealed the order of genomic events in tumor evolution. Following biallelic inactivation of NF1, loss of CDKN2A or TP53 with or without inactivation of polycomb repressive complex 2 (PRC2) leads to extensive somatic copy-number aberrations (SCNA). Distinct pathways of tumor evolution are associated with inactivation of PRC2 genes and H3K27 trimethylation (H3K27me3) status. Tumors with H3K27me3 loss evolve through extensive chromosomal losses followed by whole-genome doubling and chromosome 8 amplification, and show lower levels of immune cell infiltration. Retention of H3K27me3 leads to extensive genomic instability, but an immune cell-rich phenotype. Specific SCNAs detected in both tumor samples and cell-free DNA (cfDNA) act as a surrogate for H3K27me3 loss and immune infiltration, and predict prognosis.
    Significance: MPNST is the most common cause of death and morbidity for individuals with NF1, a relatively common tumor predisposition syndrome. Our results suggest that somatic copy-number and methylation profiling of tumor or cfDNA could serve as a biomarker for early diagnosis and to stratify patients into prognostic and treatment-related subgroups. This article is highlighted in the In This Issue feature, p. 517.
    MeSH term(s) Humans ; Neurofibrosarcoma/genetics ; Neurofibrosarcoma/diagnosis ; Neurofibrosarcoma/pathology ; Histones/metabolism ; DNA Methylation ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Neurofibromatosis 1/genetics ; Genomics ; Nerve Sheath Neoplasms/genetics ; Nerve Sheath Neoplasms/metabolism
    Chemical Substances Histones ; Biomarkers, Tumor
    Language English
    Publishing date 2023-01-04
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Intramural
    ZDB-ID 2625242-9
    ISSN 2159-8290 ; 2159-8274
    ISSN (online) 2159-8290
    ISSN 2159-8274
    DOI 10.1158/2159-8290.CD-22-0786
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top